MARKET PULSE-MannKind, Rubicon, Autobytel, Ellie Mae, UniFirst
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks inched higher on Wednesday, pushing the S&P 500 to another intraday record, after data suggested the economy was slowly building momentum after a winter-related pullback earlier in the year. Dow Jones industrial average futures were up 0.07 percent at 16,460, S&P 500 futures were up 0.14 percent at 1,880.5 and Nasdaq 100 futures were down 0.03 percent at 3,649.
** MANNKIND CORP, $7.195, +78.98 pct
U.S. health advisers on Tuesday recommended approval of the company's inhaled diabetes drug, and said the experimental treatment could help some patients, especially those wary of needles typically used with traditional insulin therapy.
** RUBICON PROJECT INC, $20.2, +34.67 pct
Shares of the provider of online advertising services soared in their market debut. The shares opened at $17.50 and went above $20. The company is betting on the growing demand for digital advertising as more consumers switch to the Internet, mobile networks and digital television.
** AUTOBYTEL INC $15, +24.69 pct
The automotive marketing services company raised its forecast for organic revenue growth to 22-24 percent from 18-22 percent for the first quarter. Continued...